Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | ANPEP | P15144 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.39 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16258106 | 1.00 | ACHE (0.43) | ACHEPTGS2ANPEPTDP1PTGS1 | |
| SCHEMBL10014228 | 1.00 | ACHE (0.43) | ACHEPTGS2ANPEPTDP1PTGS1 | |
| SCHEMBL16258066 | 0.93 | KDM4E (0.40) | ACHEPTGS2ANPEPTDP1PTGS1 | |
| SCHEMBL16258104 | 0.93 | KDM4E (0.40) | ACHEPTGS2ANPEPTDP1PTGS1 | |
| SCHEMBL16521126 | 0.88 | RAPGEF4 (0.35) | ACHEPTGS2ANPEPPTGS1MEN1 | |
| SCHEMBL17070827 | 0.88 | RAPGEF4 (0.35) | ACHEPTGS2ANPEPPTGS1MEN1 | |
| SCHEMBL17108385 | 0.87 | ANPEP (0.42) | PTGS2ANPEPKDM4E | |
| SCHEMBL21919585 | 0.86 | PTGS2 (0.41) | ACHEPTGS2TDP1PTGS1MEN1 | |
| SCHEMBL10018705 | 0.85 | ACHE (0.43) | ACHEPTGS2TDP1PTGS1MEN1 | |
| SCHEMBL13614626 | 0.85 | ACHE (0.43) | ACHEPTGS2TDP1PTGS1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309388-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-09-28 | — | — | US | disclosed |
| WO-2016198143-A1 | CHIRAL DOPANTS HAVING A NORTRICYCLAN UNIT | MERCK PATENT GMBH (DE) | 2016-12-15 | — | — | WO | disclosed |
| US-20160024383-A1 | LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE SAME | DIC CORPORATION (JP) | 2016-01-28 | — | — | US | disclosed |
| EP-2806011-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME | DIC Corporation (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-8519145-B2 | Aryl compounds as PPAR ligands and their use | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2013-08-27 | — | — | US | disclosed |
| US-8519145-B2 | Aryl compounds as PPAR ligands and their use | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2013-08-27 | — | — | US | disclosed |
| US-20120271055-A1 | ARYL COMPOUNDS AS PPAR LIGANDS AND THEIR USE | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2012-10-25 | — | — | US | disclosed |
| US-20120271055-A1 | ARYL COMPOUNDS AS PPAR LIGANDS AND THEIR USE | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2012-10-25 | — | — | US | disclosed |
| US-7888519-B2 | Liquid crystals; using metastasis catalysts; reduction, hydrogenation | MERCK PATENT GESELLSCHAFT (DE) | 2011-02-15 | — | — | US | disclosed |
| US-7888519-B2 | Liquid crystals; using metastasis catalysts; reduction, hydrogenation | MERCK PATENT GESELLSCHAFT (DE) | 2011-02-15 | — | — | US | disclosed |
| EP-1768117-B1 | LIQUID CRYSTAL LIGHT MODULATING ELEMENT AND OPTICAL HEAD DEVICE | ASAHI GLASS CO LTD (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-7462297-B2 | Chiral dopants having a laterally alkylated phenyl structural element | MERCK PATENT GMBH (DE) | 2008-12-09 | — | — | US | disclosed |
| US-7462297-B2 | Chiral dopants having a laterally alkylated phenyl structural element | MERCK PATENT GMBH (DE) | 2008-12-09 | — | — | US | disclosed |
| WO-2008066356-A1 | ARYL COMPOUNDS AS PPAR LIGANDS AND THEIR USE | SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) | 2008-06-05 | — | — | WO | disclosed |
| US-7314943-B2 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2008-01-01 | — | — | US | disclosed |
| US-7314943-B2 | Pyran derivatives containing an exocyclic double bond | MERCK PATENT GMBH (DE) | 2008-01-01 | — | — | US | disclosed |
| US-5032313-A | Trifluorobenzene derivative and liquid crystal composition containing the same | CHISSO CORPORATION (JP) | 1991-07-16 | — | — | US | disclosed |
| EP-0387032-A1 | Trifluorobenzene derivatives and liquid crystal compositions containing the same | Chisso Corporation (JP) | 1990-09-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120271055-A1 | ARYL COMPOUNDS AS PPAR LIGANDS AND THEIR USE | PPARG, PPARA, PPARD | ACHE 63/4885PTGS2 2180/4885ANPEP 4072/4885 |
| US-20230309388-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE | OCIAD1, OCIAD2, SLCO4C1 | ACHE 1667/4885PTGS2 4005/4885ANPEP 4558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.